))
#2 - A biomaterial-based vaccine
Manage episode 429175496 series 3586580
内容由Accelerating Cancer Immunotherapy Research (ACIR)提供。所有播客内容（包括剧集、图形和播客描述）均由 Accelerating Cancer Immunotherapy Research (ACIR) 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
In this 2nd episode, our co-hosts discuss the use of a macro-scale material to co-deliver GMCSF and CpG, both APC stimulating agents, as well as AML antigens to kill AML cells.
GUEST: Alex Najibi is now a postdoctoral fellow at Harvard School of Engineering and Applied Sciences, studying bioengineering in David Mooney's lab.
Original study => https://pubmed.ncbi.nlm.nih.gov/31937942/
Thanks for listening! Let’s stay in touch:
- Tweet us at @ImmunoTalks
- Share our episodes on LinkedIN and Instagram
- Email us at contact@acir.org
章节
1. #2 - A biomaterial-based vaccine (00:00:00)
2. Background about the study (00:00:29)
3. GUEST: Alex Najibi (00:05:30)
3集单集
分享
